Sign in

CIK 0001819790

  • Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
814717861
Phone
+1 949-409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
  1. 4 Gift Director gave 6,016 shares (gift)
  2. 4 Option exercise Director acquired 1,333 shares (option exercise)
  3. 4 Open-market sale Director sold 35,000 shares at an average $26.08 ($912,961)
  4. 4 Option exercise Director acquired 3,350 shares (option exercise)
  5. 4 Option exercise Director acquired 3,350 shares (option exercise)
  6. 4 Option exercise Director acquired 3,350 shares (option exercise)
  7. 4 Option exercise Director acquired 3,350 shares (option exercise)
  8. 4 Option exercise Director acquired 3,350 shares (option exercise)
  9. 4 Option exercise Director acquired 3,350 shares (option exercise)
  10. 4 Option exercise Director acquired 3,350 shares (option exercise)
  11. 4 Open-market sale See Remarks sold 10,445 shares at $27.47 ($286,924)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale Chief Commercial Officer sold 4,766 shares at $30.60 ($145,840)
  20. 4 Open-market sale General Counsel sold 4,436 shares at $30.60 ($135,742)

Page 6 of 17 · 330 filings